Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ADAG
ADAG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ADAG News
Analyst Target Prices Indicate Potential for PGJ
3d ago
NASDAQ.COM
Adani Group Resolves U.S. Fraud Charges
May 15 2026
Newsfilter
Adagene to Participate in Investor Meetings
May 12 2026
Newsfilter
Adani Total Gas Reports Q4 Profit Increase Driven by CNG Demand
Apr 27 2026
Newsfilter
Muzastotug Combination Therapy Shows Significant Efficacy in Liver Cancer Treatment
Apr 17 2026
Newsfilter
Adagene Appoints New Advisory Board Member
Apr 14 2026
Newsfilter
Adagene Prices $70M Public Offering of ADSs
Apr 02 2026
seekingalpha
Adagene Announces $70 Million Public Offering Pricing
Apr 02 2026
stocktwits
Adagene Prices Public Offering, Stock Drops 14%
Apr 02 2026
seekingalpha
Adagene Prices Public Offering to Raise $70 Million
Apr 02 2026
Newsfilter
Adagene Reports 2025 Financial Results and Clinical Progress
Apr 01 2026
Newsfilter
Adagene Reports FY Earnings Exceeding Expectations
Apr 01 2026
seekingalpha
Adagene to Participate in Two Healthcare Conferences
Feb 17 2026
Newsfilter
FDA Approves Fast Track Status for ADAG's Colorectal Cancer Treatment
Dec 17 2025
NASDAQ.COM
Adagene Receives FDA Fast Track Designation for muzastotug in MSS Colorectal Cancer
Dec 16 2025
Globenewswire
Adagene Receives FDA Fast Track Designation for muzastotug in MSS Colorectal Cancer
Dec 16 2025
Newsfilter
Show More News
